where to be online

Here's what Dallas Startup Week events Houston entrepreneurs should attend

Dallas Startup Week has pivoted to online panels and chats. Here's which ones Houston innovators shouldn't miss. Getty Images

While a 4-hour trip up Interstate 45 might, in years prior, could have caused Houston entrepreneurs pause from attending the annual Dallas Startup Week, this year there's no excuse.

DSW is taking place online this year, and there are more than a couple virtual events Houston entrepreneurs need to attend. Here's which virtual events Houstonians should log on to.

Monday - The State of Fundraising in Texas

A panel of Texas-based venture experts will discuss the state of fundraising in Dallas and Texas as a whole. The panel includes:

  • Bryan Chambers, vice president of Accelerator & Investment Fund at Capital Factory
  • Cindy Revol, principal at Perot Jain
  • Laura Baldwin, managing director at Golden Seeds
  • Mike Marcantonio, principal at Live Oak Venture Partners

The virtual panel is at 9 am on Monday, August 31. More information.

Monday - Women Investing in Women

Two Houston women — Leslie Goldman, co-founder and general partner of The Artemis Fund, and Kim Raath, co-founder and CEO of Topl — are taking the virtual stage to discuss women in investing.

The virtual fireside chat is at 11 am on Monday, August 31. More information.

Monday - Innovating in co-working in a COVID-19 world

Trey Bowles and Delanie Majors from The DEC Network will host CEO and founder of Common Desk, Nick Clark, for a discussion on how COVID-19 affected co-working spaces and the entrepreneurs that used to work out of them.

The virtual panel is at 11:30 am on Monday, August 31. More information.

Tuesday - The Future of Marketing Post COVID-19

In 2020, the world changed as we know it. Hear from these marketing leaders about how the landscape will continue to change, and how you can be equipped to market your business during and after a pandemic. Panelists include:
  • Ramon Mendez, co-founder of Brand Army
  • Phil Lockhart, partner & chief digital officer of Credera
  • Michael Pratt, founder of Digital Fight Club
  • Laci McKinney, founder of The People's Voice Creative Agency
  • Jennifer Cho, executive vice president and general manager if Weber Shandwick

The virtual fireside chat is at 3:15 pm on Tuesday, September 1. More information.

Wednesday - Do You Really Know Your Customer: Customer Segmentation is Key to Success

Learn to keys to customer success from a panel of seven businesswomen, including:

  • Tracey Altman, principal, Altman Consulting
  • Sophia Johnson, founder & president at Alpha Business Images
  • Anjie Vichayanonda, founder & CEO of Leg Up Legal
  • Karen Jenkins, senior director and regional sales executive of Capital One
  • Kristy Alballero, co-founder & COO, IOOGO
  • Kristy Alballero is the co-founder and COO of IOOGO
  • Marty McDonald, CEO of Boss Women Media

The virtual fireside chat is at 10:15 am on Wednesday, September 2. More information.

Wednesday - How Smalls Can Win Big with Department of Defense

Learning to win government contracts can be a challenging task, yet millions of startups in the United States are thriving because of them. As a founder, entrepreneur, or just a curious individual, check out this session to learn about the keys to success in government contracting. Panelists include:

  • David Shaw, co-founder and chief commercialization officer at Astrapi
  • Steve Guengerich, senior adviser at the University of Texas at Dallas
  • Dave Copps, CEO of Hypergiant Sensory Sciences
  • Sam Riehn, business development at Long Capture & Contract Management

The virtual fireside chat is at 11 am on Wednesday, September 2. More information.

Thursday - The State of Corporate Venture

A panel of experts from some of the largest corporations in the world discuss how their companies work with and invest in startups. They will discuss ways to engage with them, what kinds of companies they look to invest in, and how investing has changed during a tumultuous 2020.

  • Duane Dankesreiter, senior vice president of Research and Innovation of Dallas Regional Chamber
  • Aman Sharma, partner of Capital One Ventures
  • Marisa Bertha, senior director at New Business Development & 7-Ventures, 7-Eleven
  • Jim Adler, founding managing director at Toyota Ventures

The virtual fireside chat is at 1:05 pm on Thursday, September 3. More information.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News